<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250930067436N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-01-25</date_registration>
      <primary_sponsor>The University of Kashan</primary_sponsor>
      <public_title>Selected Corrective Exercises and Their Impact on Posture</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Selected Corrective Exercises on Postural Indices in Myopic Individuals with Upper Crossed Syndrome</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-04-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>32</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/86660</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: The distinctive aspect of this study lies in its focus on myopic individuals diagnosed with upper crossed syndrome and the implementation of a selected corrective exercise program designed according to specific postural indicators, namely forward head angle and rounded shoulder degree. Furthermore, to minimize potential participant attrition during the intervention period, the final sample size was increased from 28 to 32 participants.This quasi-experimental design enables a direct comparison of the effects of corrective exercises with a control group and facilitates the evaluation of pre- and post-intervention changes, thereby providing insight into the efficacy of corrective exercises in improving postural alignment among myopic individuals with upper crossed syndrome, Randomization description: To allocate participants to the experimental and control groups, simple randomization with an individual unit was used. Each participant was assigned a unique identification number, and the random sequence was generated using SPSS software. The first 16 numbers were assigned to the experimental group, and the next 16 numbers to the control group.
To prevent bias, the allocation sequence was placed in sealed envelopes, so that neither the researcher nor the participants were aware of the group assignment until the time of allocation.
Stratified randomization was not used in this study because the baseline characteristics of the participants were homogeneous, Blinding description: This study is a randomized controlled clinical trial with a pretest–posttest design.
Eligible participants were enrolled after obtaining written informed consent and were randomly allocated to the intervention and control groups.
Due to the nature of the exercise-based intervention, full blinding was not feasible. However, the outcome assessor was blinded to group allocation, and participants were not informed about the study hypothesis or their group assignment.
All participants received a full explanation of the study objectives and procedures and provided written informed consent prior to participation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Upper Crossed Syndrome.</hc_freetext>
      <i_freetext>The program includes a combination of stretching, strengthening, and postural correction exercises..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The shared dataset will include de-identified individual participant data after removal of all direct and indirect identifiers. Data eligible for sharing will comprise key demographic variables, primary and secondary outcome measures, and variables used in the main statistical analyses. Raw data containing identifiable information, complete medical records, or participant contact details will not be shared.

When:
Data will be available starting 6 months after publication of the primary study results and will remain accessible for a period of 5 years.

To whom:
Access may be granted to qualified researchers affiliated with academic institutions, research centers, or recognized scientific organizations. Requests from industry researchers may also be considered upon submission of a scientifically sound research proposal and approval by the relevant review committee.

Conditions:
The data may be used solely for scientific research purposes, including secondary analyses. Applicants must submit a clear research proposal and sign a data use agreement committing to ethical use and non-attempt of participant re-identification. Commercial use, data redistribution, or any use beyond the approved scope is not permitted.

Where to obtain:
Requests for data access should be submitted by contacting the corresponding investigator of the study via email.
If required, requests will be forwarded to the relevant scientific or ethics committee for review.

How to obtain:
Upon receipt of a request, the research proposal will be reviewed by the study team. If necessary, the request will be evaluated by the relevant scientific or ethics committee. Following final approval and signing of a data use agreement, the data will be shared through a secure method. This process typically takes 4 to 8 weeks.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Neda kazemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 1, Shadab Ave., Amirkabir Blvd.</address>
        <city>Kashan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8718653897</zip>
        <telephone>+98 31 5534 5091</telephone>
        <email>Kazemi.neda89@gmail.com</email>
        <affiliation>Tolu-e Mehr Nonprofit University, Qom</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Neda kazemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.1, Shadab Ave., Amirkabir Blvd</address>
        <city>Kashan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8718653897</zip>
        <telephone>+98 31 5534 5091</telephone>
        <email>Kazemi.neda89@gmail.com</email>
        <affiliation>Tolu-e Mehr Nonprofit University, Qom</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having myopia (nearsightedness) confirmed by an optometrist
The presence of upper crossed syndrome symptoms, including forward head and rounded shoulders, confirmed by postural assessments
Having the ability to perform corrective exercises
Having a body mass index (BMI) below 25
Having a written consent form to participate in the study and full cooperation during the assessment and exercise phases
Female students
Age between 18 and 25 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>25 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Having prior experience participating in related corrective exercise programs during the past six months
Presence of musculoskeletal injuries, especially in the neck, shoulder, and spinal regions
Having balance problems or severe uncorrected visual impairments
Having progressive neuromuscular or musculoskeletal disorders
Having undergone surgery in the head, neck, shoulder, or spinal region within the past year
Starting a similar exercise program or undergoing physiotherapy outside the scope of the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The program includes a combination of stretching, strengthening, and postural correction exercises.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Upper Crossed syndrome. Timepoint: Before and after the intervention. Method of measurement: 3D motion analysis software.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The University of Kashan</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-01-18</approval_date>
        <contact_name>Ethics committee of the Faculaty of Sport and Health Sciences</contact_name>
        <contact_address>Faculty of Physical Education and Sport Sciences, between 15th and 16th St., North Kargar st Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
